CMPS COMPASS Pathways plc

8.650USD+6.53%Mkt Cap: 1.23B USDP/E: —

COMPASS Pathways plc operates as a biotechnology company that focuses on mental health in the United Kingdom and the United States. The company develops COMP360, a psilocybin therapy, which is in Phase III clinical trial…

Institutional holders20 on file

Key Statistics

Company
Market Cap1.23B USD
Enterprise Value761.10M USD
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-287.86M USD
Revenue/Share—
Last Price8.650 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees156
CountryUS
SectorHealthcare
IndustryMedical Care Facilities
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-5.47
PEG—
EV/EBITDA-3.74
EV/Revenue—
P/S—
P/B8.62
EPS (TTM)-2.34 USD
EPS (Forward)-1.44 USD
52W Range
4.88034% of range15.87
52W High15.87 USD
52W Low4.880 USD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE544.70%
ROA-136.85%
ROIC—
ROCE—
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-157.24M USD
CapEx (TTM)—
FCF Margin—
FCF Yield2.96%
Net Debt-389.59M USD
Net Debt/EBITDA1.92
Net Debt/FCF-10.75
Balance Sheet
Debt/Equity-0.66
Current Ratio1.50
Quick Ratio1.41
Book Value/Sh1.00 USD
Cash/Share3.13 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.3 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)23.31 USD
Upside (mean)+169.5%
Target Range10.00 USD – 65.00 USD
10.00+169.5% to mean65.00
# Analysts16
Ownership
Shares Out.141.71M
Float110.20M
Insiders7.45%
Institutions71.52%
Short Interest
Short Ratio7.0d
Short % Float12.29%
Short % Out.12.14%
Shares Short17.20M
Short (prev mo.)17.03M
Technical
SMA 5011.79 (-26.6%)
SMA 20010.49 (-17.6%)
Beta2.41
S&P 52W Chg12.08%
Avg Vol (30d)3.20M
Avg Vol (10d)4.04M
Technical Indicators
RSI (14)39.8
MACD-0.8818
MACD Signal-0.8739
MACD Hist.-0.0078
BB Upper12.57 USD
BB Middle9.549 USD
BB Lower6.531 USD
BB Width63.22%
ATR (14)0.7591 USD
Vol Ratio (20d)0.80x

About COMPASS Pathways (NASDAQ: CMPS)

›

COMPASS Pathways (NASDAQ: CMPS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Medical Care Facilities industry, part of the Healthcare sector, and reports about 156 employees.

The shares were at 8.650 USD on 19 November 2026, up 51.8% over 52 weeks. Its 52-week range is 4.880 USD to 15.87 USD: the price is 45.5% below the high and 77.3% above the low.

Its market capitalisation is 1.23B USD.

COMPASS Pathways reports an operating margin of 0.0%.

It holds more cash than debt, a net cash position of 389.59M USD. Its Piotroski F-score is 1 out of 9, a weak reading of its financial health. 16 analysts cover the stock, with an average rating of Strong Buy; their mean price target of 23.31 USD is 169.5% above the current price. The next earnings report is expected on 23 March 2027.